Longitudinal assessment of benefits and harms of cannabis use among community-based cancer patients during initial cancer treatment

$6.28M USD

Funder	NATIONAL CANCER INSTITUTE
Recipient Organization	Georgetown University
Country	United States
Start Date	Sep 19, 2023
End Date	Aug 31, 2028
Duration	1,808 days
Number of Grantees	2
Roles	Co-Investigator; Principal Investigator
Data Source	NIH (US)
Grant ID	`10931487`

Grant Description

Despite federal prohibition on the sale or prescribing of cannabis and cannabinoids (CAC), their medical use has been legalized in 37 states. Although there is limited evidence of its effectiveness, 18-42% of persons with cancer report using CAC to help manage symptoms, most of whom obtain advice from local CAC dispensaries

rather than their oncology providers. Almost 50% of oncologists recommend CAC for their patients, but